Literature DB >> 32618612

Panorama of mediators in postpancreatitis diabetes mellitus.

Maxim S Petrov1.   

Abstract

PURPOSE OF REVIEW: To provide an overview of mediators involved in the pathogenesis of postacute pancreatitis diabetes mellitus. RECENT
FINDINGS: The 'holistic prevention of pancreatitis' framework has brought to the fore the sequelae of not only end-stage chronic pancreatitis and extensive pancreatic necrosis but also mild acute pancreatitis. Insights from the DORADO project have provided a wealth of information on the signalling molecules that do and do not affect glucose metabolism in individuals after mild acute pancreatitis and have challenged conventional views of the pathogenesis of postpancreatitis diabetes mellitus.
SUMMARY: Growing evidence compels a reconsideration of the dogma that mechanical β-cell destruction (and the resulting insulin deficiency) is the only underlying mechanism of postpancreatitis diabetes mellitus. Chronic low-grade inflammation, β-cell compensation, lipolysis, altered secretion of gut hormones, and changes in iron metabolism characterize postacute pancreatitis diabetes mellitus. Some of these are druggable targets that offer novel opportunities to reduce the burden of pancreatitis through tertiary prevention.

Entities:  

Year:  2020        PMID: 32618612     DOI: 10.1097/MOG.0000000000000654

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  15 in total

Review 1.  Intra-pancreatic fat deposition: bringing hidden fat to the fore.

Authors:  Maxim S Petrov; Roy Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-08       Impact factor: 46.802

Review 2.  The spectrum of diabetes in acute and chronic pancreatitis.

Authors:  Søren S Olesen; Frederico G S Toledo; Phil A Hart
Journal:  Curr Opin Gastroenterol       Date:  2022-07-18       Impact factor: 2.741

3.  Chronic Pancreatitis Is Characterized by Elevated Circulating Periostin Levels Related to Intra-Pancreatic Fat Deposition.

Authors:  Juyeon Ko; Charlotte E Stuart; Andre E Modesto; Jaelim Cho; Sakina H Bharmal; Maxim S Petrov
Journal:  J Clin Med Res       Date:  2020-08-15

4.  Association between Habitual Dietary Iron Intake and Glucose Metabolism in Individuals after Acute Pancreatitis.

Authors:  Wandia Kimita; Xinye Li; Juyeon Ko; Sakina H Bharmal; David Cameron-Smith; Maxim S Petrov
Journal:  Nutrients       Date:  2020-11-22       Impact factor: 5.717

Review 5.  Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus.

Authors:  Phil A Hart; Dana K Andersen; Maxim S Petrov; Mark O Goodarzi
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

6.  Pancreatitis, Pancreatic Cancer, and Their Metabolic Sequelae: Projected Burden to 2050.

Authors:  Jaelim Cho; Maxim S Petrov
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

7.  The Relationship between Abdominal Fat Phenotypes and Insulin Resistance in Non-Obese Individuals after Acute Pancreatitis.

Authors:  Juyeon Ko; Loren Skudder-Hill; Jaelim Cho; Sakina H Bharmal; Maxim S Petrov
Journal:  Nutrients       Date:  2020-09-21       Impact factor: 5.717

8.  Dietary Fibre Intake in Type 2 and New-Onset Prediabetes/Diabetes after Acute Pancreatitis: A Nested Cross-Sectional Study.

Authors:  Xinye Li; Wandia Kimita; Jaelim Cho; Juyeon Ko; Sakina H Bharmal; Maxim S Petrov
Journal:  Nutrients       Date:  2021-03-29       Impact factor: 5.717

9.  Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study.

Authors:  Sakina H Bharmal; Wandia Kimita; Juyeon Ko; Maxim S Petrov
Journal:  Endocr Connect       Date:  2021-06-29       Impact factor: 3.335

Review 10.  Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Authors:  Eleonóra Gál; Jurij Dolenšek; Andraž Stožer; László Czakó; Attila Ébert; Viktória Venglovecz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.